PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1401420
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1401420
Global Peripheral Vascular Stents Market is valued at approximately USD 1.67 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.4% over the forecast period 2023-2030. A peripheral vascular stent is a medical device designed to treat narrowed or blocked blood vessels in the peripheral arteries, which are located outside the heart and brain. These arteries supply blood to the limbs, including the legs, arms, and pelvis. It is used to treat Peripheral Artery Disease (PAD)a condition that results in narrowing of the arteries that supply blood to the legs, arms, and other parts of the body. The rise in incidences of PAD, increasing awareness of PAD among healthcare professionals and the population, and the rising number of government initiatives are the most prominent factors that are fueling the market demand across the globe.
Additionally, the growing geriatric population is exhibiting a positive influence on market growth during the estimated period. The aging population is more prone to develop vascular diseases, including PAD. As per the United Nations, there were 703 million people aged 65 years or over in the world in 2019. The number of older people is projected to double to 1.5 billion in 2050. As a result, with the increasing elderly population, the demand for peripheral vascular stents also rises, which is accelerating the market expansion worldwide. Moreover, growing investment in the advancements in stent technology, as well as the increasing focus on the development of healthcare infrastructure presents various lucrative opportunities over the forecast years. However, the high cost of procedures and the availability of other treatment options are hindering the market growth throughout the forecast period of 2023-2030.
The key regions considered for the Global Peripheral Vascular Stents Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the presence of a well-established healthcare infrastructure that includes advanced healthcare facilities. Peripheral vascular stents are easily accessible to patients in the region because of this advanced medical infrastructure, which aids in the diagnosis and treatment of CVDs. For instance, according to the Centers for Disease Control and Prevention latest report released in October 2022, a heart attack arises in the United States every 40 seconds, and every year, 805,000 Americans are estimated to have a heart attack. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecast years. Factors such as sedentary lifestyles, unhealthful eating patterns, and an aging population, all contribute to the rising prevalence of illnesses such as PAD. Accordingly, the need for efficient therapeutic alternatives such as peripheral vascular stents is increasing. Moreover, the increasing geographical expansion of the key market players and technological advancements in the field of peripheral vascular stents are significantly propelling the market demand across the region.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of tables and figures and dummy in nature, final lists may vary in the final deliverable